User contributions for JDoerfler
Appearance
2 September 2024
- 12:4812:48, 2 September 2024 diff hist +1 Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme No edit summary
- 12:4712:47, 2 September 2024 diff hist +261 Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme No edit summary
- 12:0812:08, 2 September 2024 diff hist 0 Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial No edit summary
- 12:0012:00, 2 September 2024 diff hist 0 Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial No edit summary
- 11:5911:59, 2 September 2024 diff hist 0 Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial No edit summary
- 11:5811:58, 2 September 2024 diff hist −3 Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial No edit summary
- 11:5711:57, 2 September 2024 diff hist +5 Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial No edit summary
- 11:5611:56, 2 September 2024 diff hist +261 Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial No edit summary
- 09:4409:44, 2 September 2024 diff hist +2 Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer No edit summary
- 09:4409:44, 2 September 2024 diff hist −1 Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer No edit summary
- 09:4409:44, 2 September 2024 diff hist +2 Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer No edit summary
- 09:3909:39, 2 September 2024 diff hist +1 Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer No edit summary
- 09:1509:15, 2 September 2024 diff hist −1 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary
- 09:1309:13, 2 September 2024 diff hist +1 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary
- 09:1209:12, 2 September 2024 diff hist +2 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary
- 09:0809:08, 2 September 2024 diff hist +1 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary
- 09:0809:08, 2 September 2024 diff hist +257 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary
- 09:0309:03, 2 September 2024 diff hist +1 Dörr et al. (2007): Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy No edit summary
- 08:5708:57, 2 September 2024 diff hist +261 Dörr et al. (2007): Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy No edit summary
- 08:4908:49, 2 September 2024 diff hist +32 Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects No edit summary
- 08:4708:47, 2 September 2024 diff hist +2 Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects No edit summary
- 08:4708:47, 2 September 2024 diff hist −3 Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects No edit summary
- 08:4608:46, 2 September 2024 diff hist +261 Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects No edit summary
30 August 2024
- 13:5213:52, 30 August 2024 diff hist +254 Lian et al. (2014): Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Study No edit summary
- 13:3413:34, 30 August 2024 diff hist +8 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 13:3313:33, 30 August 2024 diff hist +1,782 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 13:1313:13, 30 August 2024 diff hist +231 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 13:0913:09, 30 August 2024 diff hist +335 Jatoi et al. (2002): Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study No edit summary
- 12:5712:57, 30 August 2024 diff hist +272 Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial No edit summary
- 12:4812:48, 30 August 2024 diff hist +547 Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial No edit summary
- 12:3312:33, 30 August 2024 diff hist +290 Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain No edit summary
- 12:2712:27, 30 August 2024 diff hist +355 Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary
- 11:5911:59, 30 August 2024 diff hist +270 Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy No edit summary
- 11:5611:56, 30 August 2024 diff hist +270 Togni et al. (2015): Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial No edit summary
- 11:5311:53, 30 August 2024 diff hist +9 Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial No edit summary
- 11:5011:50, 30 August 2024 diff hist +266 Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial No edit summary
22 August 2024
- 09:1909:19, 22 August 2024 diff hist 0 Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients No edit summary
- 09:1709:17, 22 August 2024 diff hist +260 Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients No edit summary
- 09:1409:14, 22 August 2024 diff hist +260 Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue No edit summary
20 August 2024
- 13:1013:10, 20 August 2024 diff hist +14 Lian et al. (2014): Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Study No edit summary
- 13:0813:08, 20 August 2024 diff hist +2 Lian et al. (2014): Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Study No edit summary
- 13:0513:05, 20 August 2024 diff hist −4 Henning et al. (2015): Randomized Clinical Trial of Brewed Green and Black Tea in Men With Prostate Cancer Prior to Prostatectomy No edit summary
- 13:0413:04, 20 August 2024 diff hist −4 Kessels et al. (2017): Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial No edit summary
- 12:5112:51, 20 August 2024 diff hist −3 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 12:0212:02, 20 August 2024 diff hist 0 Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial No edit summary
- 11:5311:53, 20 August 2024 diff hist −14 Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary
9 August 2024
- 13:1213:12, 9 August 2024 diff hist −4 Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy No edit summary
- 13:1113:11, 9 August 2024 diff hist −3 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
8 August 2024
- 09:2909:29, 8 August 2024 diff hist +10 Crew et al. (2012): Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer No edit summary
- 07:1007:10, 8 August 2024 diff hist +13 Dos Santos Martins (2016): Placebo-Controlled, Double-Blind, Randomized Study of a Dry Guarana Extract in Patients with Head and Neck Tumors Undergoing Chemoradiotherapy: Effects on Fatigue and Quality of Life No edit summary